August 2, 2025BMC Health Services ResearchOpen Access

Decolonizing global health: Africa’s pursuit of pharmaceutical sovereignty

View Full Paper

Ask AI

Bookmark

Africa's reliance on imported medicines stems from colonial legacies and current patent laws.
Barriers to pharmaceutical sovereignty include weak regulatory capacity and chronic under-investment in local industry.
Opportunities exist in regulatory harmonization and pooled-demand instruments to enhance local production.
Realizing pharmaceutical sovereignty depends on easing intellectual property constraints and mobilizing local finance.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Literature review identifies barriers and opportunities for pharmaceutical sovereignty in Africa, suggesting regulatory reforms and technology transfer partnerships are crucial.

Cite This Study

Mulumba et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d0095 https://doi.org/10.1186/s12913-025-13211-9

View Full Paper

Ask AI

Bookmark

Implication

Literature review identifies barriers and opportunities for pharmaceutical sovereignty in Africa, suggesting regulatory reforms and technology transfer partnerships are crucial.

Decolonizing global health: Africa’s pursuit of pharmaceutical sovereignty

Key Points

Discussion

Implication

Cite This Study

Decolonizing global health: Africa’s pursuit of pharmaceutical sovereignty

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider